Ximelagatran or warfarin in atrial fibrillation? Journal Articles

authors

• Eikelboom, John
• Hankey, Graeme

status

• published 

publication date

• February 2004

has subject area

• 11 Medical and Health Sciences (FoR)
• Anticoagulants (MeSH)
• Atrial Fibrillation (MeSH)
• Azetidines (MeSH)
• Benzylamines (MeSH)
• General & Internal Medicine (Science Metrix)
• Humans (MeSH)
• Prodrugs (MeSH)
• Randomized Controlled Trials as Topic (MeSH)
• Research Design (MeSH)
• Risk (MeSH)
• Stroke (MeSH)
• Thromboembolism (MeSH)
• Treatment Outcome (MeSH)
• Warfarin (MeSH)

published in

• The Lancet  Journal

keywords

• Anticoagulants
• Atrial Fibrillation
• Azetidines
• Benzylamines
• Humans
• Prodrugs
• Randomized Controlled Trials as Topic
• Research Design
• Risk
• Stroke
• Thromboembolism
• Treatment Outcome
• Warfarin

Digital Object Identifier (DOI)

• 10.1016/s0140-6736(04)15675-4

PubMed ID

• 15001334

start page

• 734

end page

• 734

volume

• 363

issue

• 9410